|
RBM19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.785300E-04 |
| Normal-vs-Stage3 |
2.62380000004558E-06 |
| Normal-vs-Stage4 |
6.09229999781746E-08 |
| Stage1-vs-Stage2 |
1.807620E-01 |
| Stage1-vs-Stage3 |
7.157000E-03 |
| Stage1-vs-Stage4 |
7.442600E-01 |
| Stage2-vs-Stage3 |
5.827400E-01 |
| Stage2-vs-Stage4 |
4.113200E-01 |
| Stage3-vs-Stage4 |
8.840500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65423230669148E-14 |
| Normal-vs-AfricanAmerican |
5.7720050961052E-11 |
| Normal-vs-Asian |
2.882000E-02 |
| Caucasian-vs-AfricanAmerican |
5.295400E-03 |
| Caucasian-vs-Asian |
4.859800E-01 |
| AfricanAmerican-vs-Asian |
6.819200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08988382155439E-12 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
9.663700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.997700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(61-80Yrs) |
6.11743988798708E-12 |
| Normal-vs-Age(81-100Yrs) |
2.753700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.412600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.743800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.003000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.508200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.860800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.868800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.12349999999528E-05 |
| Normal-vs-Grade 2 |
1.67776903481354E-12 |
| Normal-vs-Grade 3 |
2.3239965507571E-11 |
| Normal-vs-Grade 4 |
1.27910000002895E-06 |
| Grade 1-vs-Grade 2 |
5.498700E-03 |
| Grade 1-vs-Grade 3 |
2.557500E-04 |
| Grade 1-vs-Grade 4 |
4.284300E-03 |
| Grade 2-vs-Grade 3 |
1.939040E-01 |
| Grade 2-vs-Grade 4 |
6.283200E-01 |
| Grade 3-vs-Grade 4 |
6.662600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63791202822949E-12 |
| Normal-vs-ccB subtype |
1.71880000232605E-08 |
| ccA subtype-vs-ccB subtype |
1.815180E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33968400209505E-12 |
| Normal-vs-N1 |
1.328240E-02 |
| N0-vs-N1 |
9.366400E-01 |
|
|
